Effects of mixed nut consumption on LDL cholesterol, lipoprotein(a), and other cardiometabolic risk factors in overweight and obese adults.


Journal

Nutrition, metabolism, and cardiovascular diseases : NMCD
ISSN: 1590-3729
Titre abrégé: Nutr Metab Cardiovasc Dis
Pays: Netherlands
ID NLM: 9111474

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 30 09 2022
revised: 06 05 2023
accepted: 09 05 2023
medline: 10 7 2023
pubmed: 2 6 2023
entrez: 1 6 2023
Statut: ppublish

Résumé

Elevated LDL-C, lipoprotein(a) [Lp(a)], and inflammation are associated with greater risk for atherosclerotic cardiovascular events. Consumption of individual nut types decreases these risk factors but knowledge about the effect of mixed nuts on Lp(a) is limited. The objective of this study was to determine the effects of consuming 42.5 g/day of mixed nuts on LDL-C, Lp(a), and inflammatory markers in individuals with overweight or obesity. In a 16-week randomized control trial, 29 participants with overweight or obesity (BMI 25-40 kg/m Consumption of mixed nuts had no evidence of an effect on LDL-C or Lp(a) throughout the intervention. Notably, mixed nut consumption lowered body fat percentage without significant changes in body weight or BMI. Future studies with larger sample sizes investigating the changing trends of CRP, 8-oxodG, and TAC are warranted. NCT03375866.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
Elevated LDL-C, lipoprotein(a) [Lp(a)], and inflammation are associated with greater risk for atherosclerotic cardiovascular events. Consumption of individual nut types decreases these risk factors but knowledge about the effect of mixed nuts on Lp(a) is limited. The objective of this study was to determine the effects of consuming 42.5 g/day of mixed nuts on LDL-C, Lp(a), and inflammatory markers in individuals with overweight or obesity.
METHODS AND RESULTS RESULTS
In a 16-week randomized control trial, 29 participants with overweight or obesity (BMI 25-40 kg/m
CONCLUSION CONCLUSIONS
Consumption of mixed nuts had no evidence of an effect on LDL-C or Lp(a) throughout the intervention. Notably, mixed nut consumption lowered body fat percentage without significant changes in body weight or BMI. Future studies with larger sample sizes investigating the changing trends of CRP, 8-oxodG, and TAC are warranted.
CLINICAL TRIAL REGISTER UNASSIGNED
NCT03375866.

Identifiants

pubmed: 37263914
pii: S0939-4753(23)00196-5
doi: 10.1016/j.numecd.2023.05.013
pii:
doi:

Substances chimiques

Cholesterol, LDL 0
Lipoprotein(a) 0
Adiponectin 0
8-Hydroxy-2'-Deoxyguanosine 88847-89-6

Banques de données

ClinicalTrials.gov
['NCT03375866']

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1529-1538

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors disclose no conflict of interest.

Auteurs

Chelsea L Nora (CL)

School of Exercise and Nutritional Sciences, San Diego State University, San Diego, CA, 92182, USA.

Liyue Zhang (L)

School of Exercise and Nutritional Sciences, San Diego State University, San Diego, CA, 92182, USA.

Robert J Castro (RJ)

School of Exercise and Nutritional Sciences, San Diego State University, San Diego, CA, 92182, USA.

Amanda Marx (A)

School of Exercise and Nutritional Sciences, San Diego State University, San Diego, CA, 92182, USA.

Hannah B Carman (HB)

School of Exercise and Nutritional Sciences, San Diego State University, San Diego, CA, 92182, USA.

Tiffany Lum (T)

School of Exercise and Nutritional Sciences, San Diego State University, San Diego, CA, 92182, USA.

Sotirios Tsimikas (S)

School of Medicine, University of California, San Diego, La Jolla, CA, 92093, USA.

Mee Young Hong (MY)

School of Exercise and Nutritional Sciences, San Diego State University, San Diego, CA, 92182, USA. Electronic address: mhong2@sdsu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH